The B-21 Raider and the future of the Air Force bomber force

The B-21 Raider and the future of the Air Force bomber force


The Air Force needs some new bombers. The B-1B Lancer and B-2A Spirit are in the twilight of their careers, and the B-21 Raider, a new stealth bomber produced by Northrop Grumman aims to take over the role as the premier bomber for the United States.

‘Our adversary’s defenses have increased tremendously, since the advent of the B-2,” said Thomas DiNanno, adjunct fellow at the Hudson Institute. “Chinese and Russian air defense systems, the S-400, the S-500, are highly capable, they’re extremely dangerous. And so the modernizing advanced stealth capabilities is important.”

Digital design, focused requirements by the Air Force and previous experience by Northrop Grumman in fielding a stealthy flying wing are credited with why the program appears to be on track and on budget.

“The B-21 looks very similar to the B-2 because the fundamentals of stealth and long-range penetrating air are built around the concept of a flying wing,” said Doug Young, vice president and general manager, strike division at Northrop Grumman. “And that even goes back to the YB-49 jet when Jack Northrop actually created some of the first flying wings.’

Watch the video above to find out more about the new high-tech stealth bomber slated to fly in 2023.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More